The effect of tanshinone IIA on renal and liver functions in ovine fetuses in utero

Drug and Chemical Toxicology

Volumn 32, Issue 4, 2009, Pages 362-371

  Zhang, Yifan ^b   Can, Rui ^a   Mao, Caiping ^a   Zhang, Yuying ^a   Zhu, Liyan ^a   Shao, Huan ^c   Wang, Liping ^c   Wang, Aiqing ^a   Xu, Zhice ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

^c WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Fetus; Heptic and renal functions; Pregnancy; Tanshinone IIA

Indexed keywords

SODIUM CHLORIDE; TANSHINONE IIA; DAN SHEN ROOT EXTRACT; DAN-SHEN ROOT EXTRACT; HERBACEOUS AGENT; PHENANTHRENE DERIVATIVE; PHENANTHROLINE DERIVATIVE; POTASSIUM CHANNEL KCNQ1; TANSHINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROLYTE URINE LEVEL; ENZYME ACTIVITY; EWE; FEMALE; FETUS; HERBAL MEDICINE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIVER FUNCTION; NONHUMAN; PREGNANCY; SALVIA MILTIORRHIZA; URINARY EXCRETION; URINE OSMOLALITY; URINE VOLUME; ANIMAL; BREEDING; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; KIDNEY; LIVER; LIVER MICROSOME; METABOLISM; PHYSIOLOGY; SHEEP; UTERUS;

OVIS;

ANIMALS; DRUGS, CHINESE HERBAL; FEMALE; FETUS; KCNQ1 POTASSIUM CHANNEL; KIDNEY; LIVER; MICROSOMES, LIVER; PHENANTHRENES; PHENANTHROLINES; PREGNANCY; PREGNANCY, ANIMAL; SALVIA MILTIORRHIZA; SHEEP; UTERUS;

EID: 74049148572     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540903176594     Document Type: Article

References (33)

1. Bensky, D., Gamble, A., Kaptchuk, T. (1993). Chinese Herbal Medicine: Materia Medica (2nd ed.) (pp 267-268). Seattle, Washington, USA: East.
2. Chen, D. J., Zhao, Y., She, R. J., Wen, L.Z., Su, C.H., Huang, Y.Y., et al. (2003). Effect of Salvia miltiorrhiza, ligustrazine, and magnesium sulfate on outcomes of patients with pregnancy- induced hypertension. Chin J Perinat Med 6:259-262.
3. Cheng, J., Kuang, P., Wu, W., Zhang, F. (1999). Effects of transient forebrain ischemia and Radix Salviae miltiorrhizae (RSM) on extracellular levels of monoamine neurotransmitters and metabolites in the gerbil striatum an in vivo microdialysis study. J Trad Chin Med 19:135-140.
4. Cui, S.K., Li, G.H. (2003). Clinical effect of Fufang Danshen dripping pill on hyperlipemia. Mod J Integr Chin Trad West Med 11:1029-1030.
5. Ding, Y., Zhao, L., Mei, H., Huang, Z.H., Zhang, S.L. (2006). Alterations of biliary biochemical constituents and cytokines in infantile hepatitis syndrome. World J Gastroenterol 12:7038-7041.
6. Eric, J., Gurmit, P., Christine, G. (2000). Blood biochemistry and endocrinology in the human fetus between 11 and 17 weeks of gestation. Reprod Biol Med 10:38-44.
7. Feng, J.F., Chen, T.M., Wen, Y.A., Wang, J., Tu, Z.G. (2008). Study of serum argininosuccinate lyase determination for diagnosis of liver diseases. J Clin Lab Anal 22:220-227.
8. Ji, X.Y., Tan, B.K., Zhu, Y.Z. (2000). Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol Sinica 21:1089-1094.
9. Kang, D.G., Yun, Y.G., Ryoo, J.H., Lee, H.S. (2002). Antihypertensive effect of water extract of Danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 30:87-93.
10. Kim, D.D., Sánchez, F.A., Durán, R.G., Kanetaka, T., Durán, W.N. (2007). Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb, Danshen, in hypertension. Am J Physiol Heart Circ 292:2131-2137.
11. Lam, B.Y., Lo, A.C., Sun, X., Luo, H.W., Chung, S.K., Sucher, N.J. (2003). Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10:286-291.
12. Lei, X.L., Chiou, G.C.Y. (1986). Studies on cardiovascular actions of Salvia miltiorrhiza. Am J Chin Med 14:26-32.
13. Li, Y.L., Zhang, Y.P., Ceng, P. (2003). Analysis of allergic shock caused intrauterine fetal death induced by intravenous dripping of low molecular dextran and composita Danshen injection to pregnant women. Mod J Integr Chin Trad West Med 23:21.
14. Li, Y.M., Chen, S.H., Yu, C.H., Zhang, Y., Xu, G.Y. (2004). Effect of acute alcoholism on hepatic enzymes and oxidation/antioxidation in rats. Hepatobil Pancreat Dis Int 3:241-244.
15. Liu, Y.H. (2003). Clinical study of Yiqiyangtai decoction on intrauterine growth retardation. Hebei J Trad Chin Med 25:329-331.
16. Ma, W.Y., Yang, J.S., Ma, C.C. (2001). Effect of Danshen composite on hyperlipaemia and blood rheology. Pharmaceut J Chin People's Liberat Army 17:47-48.
17. Ma, J.Y. (1998). Clinical observation of the treatment of hyperlipemia with Danshen composite. Tianjin J Trad Chin Med 15:24.
18. Mao, C.P., Lv, J. X., Zhu, H., Zhou, Y., Chen, Y.Z., Feng, X., et al. (2007). Fetal functional capabilities in response to maternal hypertonicity associated with altered central and peripheral angiotensinogen mRNA in rats. Peptides 28:1178-1184.
19. Nissen, S.E., Tuzcu, E.M., Libby, P. (2004). The Camelot Study: effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. J Am Med Assoc 292:2217-2226.
20. Niu, X.L., Ichimori, K., Yang, X., Hirota, Y., Hoshiai, K., Li, M., et al. (2000). Tanshinone II-A inhibits low-density lipoprotein oxidation in vitro. Free Radic Res 33:305-312.
21. Shao, M. (2003). Clinical effect of Danshen injection on unstable angina pectoris. J Anhui Trad Chin Med Coll 22:13-15.
22. Takahashi, K., Ouyang, X., Komatsu, K., Nakamura, N., Hattori, M., Baba, A., et al. (2002). Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem Pharmacol 64:745-749.
23. Thorburn, G.D., Harding, R. (1994). Textbook of Fetal Physiology (pp 135-286). New York: Oxford Medical Publications.
24. Wang, A.M., Sha, S.H., Lesniak, W., Schacht, J. (2003). Tanshinone (Salviae miltiorrhizae extract) reparations attenuate aminoglycoside-induced free radical formation in vitro and toxicity in vivo. Antimicrob Agents Chemother 47:1836-1841.
25. Xia, W. J., Yang, M., Fork, T. F., Li, K., Chan, W. Y., Ng, P. C., et al. (2005). Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr Res 58:784-790.
26. Xu, Z.C., Calvario, G., Yao, J.M., Day, L., Ross, M.G. (2001a). Central angiotensin induction of fetal brain c-fos expression and swallowing activity. Am J Physiol Regulat Integrat Comparat Physiol 280:1837-1843.
27. Xu, Z.C., Nijland, M.J.M., Ross, M.G. (2001b). Plasma osmolality dipsogenic thresholds and c-fos expression in the near-term ovine fetus. Pediatr Res 49:678-685.
28. Yan, S.K. (2003). Suggestion for the measurement of blood lipids in clinical study. Chin J Lab Med 26:182-184.
29. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G. (2000). The heart outcomes prevention evaluation study investigators: effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. NEJM 342:145-153.
30. Zhang, H., Yu, C., Jia, J.Y., Leung, S.W., Siow, Y.L., Man, R.Y., et al. (2002). Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza). Acta Pharmacolog Sin 23: 1163-1168.
31. Zhou, H. (2004). The effects of Danshen injection on umbilical artery blood flow of patients with intrahepatic cholestasis of pregnancy. Chin J Informat Trad Chin Med 11: 195-196.
32. Zhou, Y.Q., Chang, C., Li, X.T., Zhuang, Y.L., Zhou, G.X., Yang, Y.M. (1999). A Doppler study of the umbilica l blood flow of the experimental animal fetus with intrauterine distress. Chin J Ultra Med 15:89-90.
33. Zhou, L.M., Zuo, Z., Chow, M.S.S. (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345-1359.